Free Trial

AstraZeneca (AZN) SEC Filings & 10K Form

AstraZeneca logo
$68.46 -5.46 (-7.39%)
Closing price 04:00 PM Eastern
Extended Trading
$68.46 0.00 (-0.01%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent AstraZeneca SEC Filings

DateFilerForm TypeView
04/01/2025
11:30 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2025
6:16 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2025
6:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2025
7:32 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
6:17 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
6:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
6:30 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2025
2:33 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
9:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
6:17 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
6:20 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2025
5:31 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
10:06 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2025
9:52 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
9:22 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
5:00 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2025
8:29 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2025
5:08 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2025
5:59 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
9:30 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
7:02 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
6:49 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2025
8:53 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
11:15 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form EFFECT
02/03/2025
12:05 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2025
5:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
8:25 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2025
8:52 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Cellectis S.A. (Subject)
Form SCHEDULE 13D/A
01/21/2025
11:17 AM
AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
Form F-6
Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts  
01/21/2025
5:40 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2025
6:13 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2025
9:04 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
10:05 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2024
11:13 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/16/2024
9:04 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2024
8:01 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
9:28 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
9:35 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2024
5:43 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
5:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This almost killed Elon Musk (chilling details emerge) (Ad)

Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.

See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro
11/15/2024
8:13 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
5:48 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
11:31 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2024
6:10 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2024
8:10 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
10:46 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
5:00 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Monopar Therapeutics (Subject)
Form SC 13G
10/21/2024
8:48 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
5:01 AM
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Form SC 13G
10/07/2024
5:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
9:45 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
5:42 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
5:44 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
5:27 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
12:34 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
9:50 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
5:05 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/16/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
9:11 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
5:26 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2024
5:00 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/26/2024
5:42 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
8:06 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
5:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
9:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
5:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2024
4:00 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
5:12 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
5:07 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
5:38 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
5:21 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2024
9:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
9:02 AM
AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
06/03/2024
9:23 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
9:29 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
5:35 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
5:15 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
5:08 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2024
5:32 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
5:41 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
6:31 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
5:49 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
6:18 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
5:52 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
5:26 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
12:22 PM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
5:55 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Trump’s Secret Weapon (Ad)

Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.

Get Your FREE Presidential Transition Guide Today
04/08/2024
5:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
5:14 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/05/2024
5:22 AM
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:AZN) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners